Pharmaceutical companies' turnover contribution set at 1% for 2007
Article 22 of the 2007 Social Security Financing Act sets at 1%, on an exceptional basis, the rate of the contribution owed by companies selling reimbursable medicines on their turnover (Article L. 245-6 of the Social Security Code), for turnover achieved in 2007. According to the Senate report, the rate was 1.76% for 2006. The government counted the measure among new revenue measures, the 1% rate remaining above the standard rate of Article L. 245-6. The 1% rate was renewed for 2008 by the 2008 Social Security Financing Act.
Measure originators
A positive amount is revenue or savings for public finances; a negative amount is a cost or lost revenue.
Measure impact
Concerns companies selling reimbursable medicines. The table of new revenue measures reproduced by the Senate attributes €100 million of revenue for social security in 2007 to the measure.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
Entrée en vigueur de la mesure et mise en œuvre par l'administration
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP
Debate and vote
Debate and vote
Débat et vote en séance publique à l'Assemblée nationale, ou engagement de la responsabilité du Gouvernement (article 49.3)